INTRODUCTION
============

The failure to wean from mechanical ventilation after cardiac surgery is associated with worse outcomes, including increased length of hospital stays and higher costs ([@b1-cln_68p33]-[@b3-cln_68p33]). In a prospective study of 885 patients who underwent coronary artery bypass grafting (CABG), Wong et al. ([@b4-cln_68p33]) identified increased age, female gender, the postoperative use of an intra-aortic balloon pump (IABP), the use of inotropes, bleeding, and atrial arrhythmia as risk factors for weaning failure and prolonged mechanical ventilation.

Perioperative ventricular dysfunction and cardiac failure are frequent causes of weaning failure from mechanical ventilation ([@b4-cln_68p33]). Prolonged cardiopulmonary bypass (CPB), inadequate myocardial protection during surgery, perioperative myocardial ischemia and previous left ventricular dysfunction are associated with a higher incidence of perioperative heart failure ([@b5-cln_68p33],[@b6-cln_68p33]). A diagnosis of low output syndrome after surgery is suggested by decreased central venous oxygen saturation (ScvO~2~), low urine output, low cardiac index, high cardiac filling pressure and elevated levels of B-type natriuretic peptide (BNP) ([@b7-cln_68p33]-[@b10-cln_68p33]).

BNP is produced by cardiac ventricular myocytes in response to volume or pressure overload. Active BNP and its inactive form, NT-proBNP, are derived from the cleavage of their precursor molecule, proBNP. BNP decreases systemic vascular resistance, improves myocardial relaxation, increases natriuresis and suppresses endothelin and the renin-angiotensin system ([@b10-cln_68p33]). The BNP levels are increased in patients who have left ventricular dysfunction, right ventricular dysfunction or valvular dysfunction. Therefore, BNP is considered to be a quantitative biomarker of heart failure ([@b10-cln_68p33]). BNP levels are also related to left ventricular dysfunction in the postoperative period, including after cardiac surgery ([@b11-cln_68p33]-[@b20-cln_68p33]). In a prospective study, Zapata et al. evaluated the value of the BNP level as a marker of failure to wean from mechanical ventilation in a mixed population of 100 medical and surgical patients (excluding cardiac surgery patients) who were treated with mechanical ventilation for over 48 h ([@b21-cln_68p33]). BNP levels predicted failure to wean cases that were caused by ventricular dysfunction, and a ΔBNP of 48 ng/L identified heart failure as the cause of failed SBT, with 91.7% sensitivity and 88.5% specificity ([@b21-cln_68p33]).

We hypothesized that BNP levels could help in the early identification of patients who cannot be weaned from mechanical ventilation due to postoperative ventricular dysfunction after cardiac surgery.

MATERIAL AND METHODS
====================

The study was approved by the Ethics Committee, and written informed consent was obtained from all patients. We prospectively included all of the patients older than 18 years who underwent elective CABG surgery with CPB during a 1-year period from January 2009 and January 2010 at Heart Institute, University of Sao Paulo. The exclusion criteria were a history of pulmonary disease or chronic renal failure, the need for IABP and consent refusal.

The patients were anesthetized according to our standard institutional protocol for CABG surgery. Preoperative medication consisted of midazolam (0.1 to 0.2 mg/kg given orally 30 minutes before surgery). Anesthesia was induced with fentanyl (3-5 μg/kg), midazolam (0.05 mg/kg), etomidate (0.2- 0.3 mg/kg), and pancuronium bromide (0.1 mg/kg). Anesthesia was maintained with isoflurane in oxygen and fentanyl as needed. During CPB, additional doses of midazolam and pancuronium were administered as required to reach a bispectral index of approximately 40-60. After the tracheal intubation, all of the patients received invasive mechanical ventilation with intermittent positive pressure with a tidal volume of 8 mL/kg, positive end-expiratory pressure of 5 to 8 cm H~2~O, and fraction of inspired oxygen (FiO~2~) of 0.6 to 1 to maintain the arterial oxygen saturation above 95%. During surgery, the patients were monitored with a central venous line and indwelling radial artery catheter. Forty-four patients also had a pulmonary artery catheter inserted if the surgical and anesthesiology teams believed that it was warranted. In these patients, the cardiac index was obtained from a continuous cardiac output monitor, Vigilance II (Edwards Lifesciences, Irvine, CA 92614 USA).

Preoperative information, including demographic data, preoperative left ventricular ejection fraction (LVEF), and the European system for cardiac operative risk evaluation score (EuroSCORE) ([@b22-cln_68p33]), were obtained for all patients. The intraoperative data, including the cardiac procedure and CPB durations and the use of inotropes or vasopressors, were also recorded. After ICU admission, the following hemodynamic parameters were obtained and recorded: heart rate, mean arterial pressure (MAP), central venous pressure (CVP), pulmonary arterial pressures, pulmonary capillary wedge pressure, cardiac output, cardiac index and systemic vascular resistance (SVR). We also recorded the mechanical ventilation parameters, including the ventilation mode, plateau pressure and positive end-expiratory pressure (PEEP), respiratory rate in controlled and spontaneous mode, fraction of inspired oxygen (FiO~2~), oxygen saturation by pulse oximetry (SpO~2~), tidal volume and minute volume, rapid shallow breathing index or respiratory rate/tidal volume ratio and static respiratory system compliance ([@b23-cln_68p33],[@b24-cln_68p33]).

A blood gas analysis and measurement of hemoglobin levels were performed and recorded after ICU admission every 6 h during the first 24 h after cardiac surgery. The Triage^®^ BNP Test (Biosite, San Diego, CA, USA) was used to determine the BNP levels in the plasma specimens through immunofluorescence, with EDTA as the anticoagulant. The BNP levels were measured immediately after ICU admission and at the end of the spontaneous breathing test (SBT). The fluid balance, need for vasopressor or inotropic support, and length of the ICU and hospital stays were also recorded.

Weaning protocol
----------------

After ICU admission, all of the patients were initially ventilated using the following parameters: synchronized intermittent mandatory ventilation (SIMV) using pressure-controlled ventilation with an I/E ratio of 1:2 and enough support pressure to give a tidal volume of approximately 8 mL/kg, 5 cm H~2~O PEEP, respiratory rate of 12 breaths/min, and FiO~2~ of 60% or greater if the SpO~2~ was less than 90%. The degree of support was reduced, if possible, by 2 to 4 cm H~2~O at least hourly. The first spontaneous breathing test was given if the patients were awake and hemodynamically stable, as defined by the absence of bleeding (chest tube drainage ≤100 ml per hour or ≤300 mL in one hour), ScvO~2~\>65%, CI\>2.2 L/min/m^2^ and MAP\>65 mmHg with low-dose norepinephrine ≤0.2 μg/Kg/min) or no vasopressor agents. Additionally, SBT was started after correcting acid-base and electrolyte disorders. The SBT test lasted 60 min and was considered failed if the patient presented with one or more of the following signs at the end of the first SBT: respiratory rate \<35 breaths/min; heart rate \<140 beats/min; SpO~2~\<90% or PaO~2~\<60 mmHg; respiratory acidosis (pH\<7.3 or PaCO~2~\>50 mmHg); signs of respiratory distress, such as thoracoabdominal dyssynchrony, anxiety and diaphoresis, or reintubation within 48 h in patients who were successful in the first SBT.

Statistical analysis
--------------------

We compared the baseline characteristics, follow-up measures, and clinical outcomes between the groups. Continuous variables were tested for normal distribution using the Kolmogorov-Smirnov test and compared using Student\'s t test or the Mann-Whitney U-test. The sample size was calculated based on a power of 80% and a 5% type-I error. Estimating an event incidence of 10%, 158 patients were needed to complete the study. An interim analysis was scheduled after 101 patients had been enrolled in the study.

The results are expressed as means with 95% confidence intervals (CIs) or medians with interquartile ranges (IQRs). A multiple logistic regression analysis was performed to assess the predictive factors for weaning failure from mechanical ventilation, and the significance level was set at *p*\<0.10 in the univariate model (i.e., the patient age, body mass index \[calculated as weight in kilograms divided by height in meters squared\], comorbidity, left ventricular ejection fraction, EuroSCORE, surgery type, CPB duration, initial and final hemoglobin concentrations, lactate concentration, and ScvO~2~ and BNP levels). We built a multivariate Cox proportional hazard model in the overall population with weaning failure as the dependent factor using the variables above.

To determine the best cut-off for BNP, we calculated the area under the receiver operating characteristic curve (AUC) and compared the BNP levels in the failed weaning group with those in the successful weaning group.

A two-sided *p-*value\<0.05 was considered statistically significant. The statistical analyses were performed using SPSS version 18.0 (SPSS Inc., Chicago, IL).

RESULTS
=======

An interim analysis was performed when 101 patients had been included, and because a significant *p*-value was found, we interrupted the data collection. Of the 101 patients studied, 12 failed the weaning trial. Of those 12 patients, five required reintubation, and seven were weaned from mechanical ventilation after they failed to wean in the first SBT. There were no differences between the groups in their baseline or intraoperative characteristics, including the left ventricular function, EuroSCORE, and the durations of the cardiac procedure and CPB bypass ([Table 1](#t1-cln_68p33){ref-type="table"}). The patients who failed weaning had longer ICU (9 ([@b4-cln_68p33]-[@b14-cln_68p33]) *vs*. 3 ([@b2-cln_68p33]-[@b5-cln_68p33]), *p* = 0.024) and hospital (15 ([@b13-cln_68p33]-[@b20-cln_68p33]) *vs*. 8 ([@b7-cln_68p33]-[@b13-cln_68p33]), *p* = 0.047) lengths of stay compared with successfully weaned patients.

The patients who failed to wean from mechanical ventilation had higher CVP values at the end of the SBT than the patients who weaned successfully (11 ([@b9-cln_68p33]-[@b15-cln_68p33]) *vs*. 9 ([@b5-cln_68p33]-[@b10-cln_68p33]) mmHg, *p* = 0.023); they also had lower ScvO~2~ values (62 \[58-65\] *vs*. 69% \[68-71\], *p* = 0.002) at this time point and required higher doses of dobutamine (15 ([@b11-cln_68p33]-[@b18-cln_68p33]) *vs*. 12 ([@b9-cln_68p33]-[@b16-cln_68p33]) μg/Kg/min, *p* = 0.044) ([Table 2](#t2-cln_68p33){ref-type="table"}). There were no differences between the groups in the other hemodynamic variables or in the cumulative fluid balance.

The BNP levels were significantly higher in the patients who failed to wean compared with those who weaned successfully, both at ICU admission (214 ng/mL \[65-487\] *vs*. 73 \[28-127\], *p* = 0.02) and after the SBT (416 ng/mL \[311-561\] *vs*. 140 \[80-226\], *p*\<0.001) ([Table 2](#t2-cln_68p33){ref-type="table"}). In the multivariate model, only BNP at the end of the SBT (BNP-2) was predictive of weaning failure from mechanical ventilation (odds ratio \[OR\], 1.006 per ng/mL \[95% CI, 1.003-1.009\]; *p*\<0.001). A BNP concentration of 299 ng/L at the end of the SBT identified weaning failure with 92% sensitivity and 88% specificity, with an AUC of 0.91 (CI 95% \[0.86 - 0.97\], *p*\<0.001) ([Figure 1](#f1-cln_68p33){ref-type="fig"}). [Figure 2](#f2-cln_68p33){ref-type="fig"}) shows the BNP concentrations for the individual patients.

Clinical outcomes
-----------------

A total of 716 patients were assessed for eligibility during the study period. In total, 101 patients were enrolled, and the mortality rate was 5%. The patients who failed to wean from mechanical ventilation after the first SBT had higher ICU mortality rates than the patients who did not fail (3 \[25%\] *vs*. 2 \[2.2%\], *p*\<0.0011). Five patients in the failure group were reintubated within 48 h after the SBT because of congestive heart failure. Two of the reintubated patients died from cardiogenic shock. Seven patients had failure to wean in the first SBT but were not reintubated in the first 48 h. One of these patients died from pneumonia, septic shock and multiple organ failure.

DISCUSSION
==========

Our study shows that a high level of BNP is an independent risk factor for the failure to wean from mechanical ventilation after cardiac surgery. In clinical practice, BNP levels are widely used to diagnose and stratify risk in heart failure patients and as a predictor of outcomes, including re-hospitalization and death ([@b10-cln_68p33],[@b25-cln_68p33]). An elevated BNP level is considered to be a biomarker of ventricular dysfunction and can identify early decompensated heart failure after cardiac surgery ([@b11-cln_68p33]-[@b14-cln_68p33],[@b16-cln_68p33]-[@b20-cln_68p33],[@b25-cln_68p33],[@b26-cln_68p33]). Elevated postoperative BNP levels have also been associated with prolonged hospital stays and mortality in patients undergoing cardiac surgery ([@b11-cln_68p33],[@b17-cln_68p33],[@b18-cln_68p33]).

Underlying left ventricular dysfunction is an important cause of weaning failure in critically ill patients, particularly during the postoperative period after cardiac surgery, and can be the result of perioperative myocardial ischemia, prolonged CPB, or inadequate myocardial protection ([@b27-cln_68p33]-[@b30-cln_68p33]). This condition may be difficult to recognize within the first 24 h after cardiac surgery. Previous studies have reported that early indirect parameters of cardiac function, such as capnometric recirculation gas tonometry and gastric intramucosal pH, were altered in patients who presented with failure to wean from mechanical ventilation. These findings can be explained by the likelihood that the increased respiratory workload during spontaneous test breathing can induce an intestinal mucosa hypoperfusion because of the adrenergic response and effort required to increase the blood flow to the respiratory muscles ([@b31-cln_68p33]-[@b33-cln_68p33]). Similarly, the BNP levels during the spontaneous breathing test might help physicians identify earlier those patients with postoperative heart failure and support decisions to discontinue mechanical ventilation after cardiac surgery, potentially decreasing the risk of weaning failure ([@b6-cln_68p33],[@b18-cln_68p33],[@b21-cln_68p33]).

All of the patients with weaning failure in the current study had higher BNP levels both at their ICU admissions and at the end of the SBT compared with the patients who had successful weaning. The highest BNP levels were found at the end of the SBT, suggesting that postoperative left ventricular dysfunction was involved in the weaning failure. In addition, these patients had higher CVP and lower ScvO~2~ levels and needed higher doses of dobutamine compared with the patients who were successfully weaned. Paulus et al. ([@b34-cln_68p33]) reported that in patients with left ventricular dysfunction who had presented a failure in the first or additional spontaneous breathing tests after cardiac surgery, the use of enoximone, a phosphodiesterase III inhibitor, was associated with an improvement in hemodynamic parameters and successful withdrawal of mechanical ventilation. Although these hemodynamic parameters were not predictors of weaning failure in our study, they reinforce our hypothesis that underlying heart failure caused weaning failure in this subgroup of patients.

A previous study showed that increased age, female gender, the postoperative use of an intra-aortic balloon pump (IABP), inotropes, bleeding, and atrial arrhythmia were risk factors of delayed extubation after cardiac surgery ([@b4-cln_68p33]). Our data did not show any differences in gender. However, our findings suggested that poor ventricular function, expressed through high levels of BNP, is a predictor of weaning failure after cardiac surgery.

In our study, the prevalence of weaning failure was 12%. This failure rate is higher than that reported in other studies ([@b1-cln_68p33]), most likely because our study was performed in a cardiac surgery referral center and included severely ill patients, as shown by the high EuroSCOREs ([@b22-cln_68p33]). The patients who had weaning failure in our study may have developed myocardial dysfunction secondary to CPB. A CPB duration of more than 120 minutes has been considered a predictive factor for weaning failure in patients after cardiac surgery in previous studies ([@b35-cln_68p33]), but there was no significant difference in the duration of CPB between our groups. Moreover, none of the patients with weaning failure met the perioperative myocardial infarction criteria. Nevertheless, the etiology of myocardial dysfunction after CPB is multifactorial and can occur even without prolonged CPB or perioperative infarction ([@b6-cln_68p33]). Using transesophageal echocardiography, Bernard et al. described a 30% rate of diastolic dysfunction after cardiac surgery with CPB ([@b27-cln_68p33]).

If BNP levels are predictors of weaning failure from mechanical ventilation in patients after cardiac surgery, as suggested by our results, and ventricular dysfunction is one cause of weaning failure, then optimizing ventricular function may result in better outcomes after cardiac surgery. A bundle of interventions could be used to optimize ventricular function during the perioperative period in such patients, including effective myocardial protection during CPB and the judicious administration of inotropic agents and vasodilators to obtain adequate cardiac indices and ScvO~2~ levels ([@b6-cln_68p33]). The careful evaluation of fluid status is also needed to prevent elevated filling pressures and pulmonary congestion.

Our study has several limitations. First, it was an observational and single-center study with a small number of patients and relatively few failure events. Second, BNP levels can be altered in various conditions in patients undergoing cardiac surgery, and we are unable to identify the exact cause of the myocardial dysfunction that caused the weaning failure in our patients. Third, there are many other conditions in critically ill patients that may be associated with increased BNP levels. Therefore, these investigations should be extended to a larger patient population in a multicenter setting.

In conclusion, our study demonstrated that a high BNP level is a predictor of weaning failure from mechanical ventilation in patients after cardiac surgery. Therefore, measuring BNP levels may help to guide and evaluate the effects of therapeutic strategies, such as optimizing ventricular function during cardiac surgery, prior to weaning from mechanical ventilation.

This report describes human research. IRB contact information: CAPPesq - Comissão de Ética para Análise de Projetos de Pesquisa (<cappesq@hcnet.usp.br>), do Hospital das Clinicas da Faculdade de Medicina da Universidade de São Paulo, São Paulo/SP, Brazil.

No potential conflict of interest was reported.

ACNOWLEDGMENTS
==============

This study was supported by the Fundação de Amparo a Pesquisa do Estado de São Paulo (FAPESP), Brazil -- Number 08553750.

![Area under receiving operating characteristic curve for BNP-2 (at the end of spontaneous breathing test) to predict weaning failure.](cln-68-01-033-g001){#f1-cln_68p33}

![Individual values of BNP concentration. A cut-off of 299 ng/L at the end of the SBT predicted failure to wean from mechanical ventilation after cardiac surgery with 92% sensitivity and 87% specificity. Red dots represent patients with weaning failure.](cln-68-01-033-g002){#f2-cln_68p33}

###### 

Baseline, intraoperative characteristics and clinical outcomes of patients.

  Variable                                          Total (101)     Successful weaning (n = 89)   Failure to wean (n = 12)   *p-*value
  ------------------------------------------------- --------------- ----------------------------- -------------------------- -----------
  Sex[\*](#tfn1-cln_68p33){ref-type="table-fn"})                                                                             
  Male                                              76 (75.2%)      69 (77.5%)                    7 (58.3%)                  0.165
  Female                                            25 (24.8%)      20 (22.5%)                    5 (41.7%)                  
  Age (years)\*\*                                   63 (61-65)      63 (61-65)                    63 (55-72)                 0.289
  LVEF (%)\*\*\*                                    54 (40-64)      54 (40-64)                    56 (40-68)                 0.560
  EuroSCORE\*\*\*                                   5 (3-7)         4 (3-7)                       6 (4-8)                    0.246
  Duration of procedure (min)\*\*\*                 270 (240-330)   270 (240-330)                 283 (240-383)              0.281
  Duration of CBP (min)\*\*\*                       95 (80-110)     94 (80-108)                   111 (91-120)               0.433
  Duration of mechanical ventilation (min) \*\*\*   420 (360-613)   420 (360-625)                 488 (390-559)              0.868
  ICU length of stay (days) \*\*\*                  3 (2-5)         3 (2-5)                       9 (4-14)                   0.024
  Hospital length of stay (days) \*\*\*             9 (7-14)        8 (7-13)                      15 (13-20)                 0.047
  Hospital Mortality                                5 (5%)          2 (2,2%)                      3 (25%)                    0.011

\*Chi-square test, \*\*mean (95% confidence Interval), t-test, \*\*\*median (interquartile range), Mann-Whitney test. EuroSCORE: European System for Cardiac Operative Risk Evaluation; LVEF: left ventricular ejection fraction; CPB: cardiopulmonary bypass.

###### 

Hemodynamic, respiratory and gas exchange variables.

  Variable                                                           Successful weaning (n = 89)   Failure to wean (n = 12)   *p-*value
  ------------------------------------------------------------------ ----------------------------- -------------------------- -----------
  Hemodynamic                                                                                                                 
  HR-1 (beats/min)[\*](#tfn2-cln_68p33){ref-type="table-fn"})        96 (92-100)                   93 (80-105)                0.435
  HR-2 (beats/min)[\*](#tfn2-cln_68p33){ref-type="table-fn"})        103 (101-106)                 96 (89-103)                0.087
  MAP-1 (mmHg)[\*](#tfn2-cln_68p33){ref-type="table-fn"})            92 (89-96)                    93 (83-102)                0.983
  MAP-2 (mmHg)[\*](#tfn2-cln_68p33){ref-type="table-fn"})            89 (87-92)                    85 (78-93)                 0.239
  PAOP-1 (mmHg)[\*](#tfn2-cln_68p33){ref-type="table-fn"})^\$^       14 (13-15)                    14 (10-17)                 0.855
  PAOP-2 (mmHg)[\*](#tfn2-cln_68p33){ref-type="table-fn"})^\$^       10 (9-12)                     12 (9-15)                  0.440
  CVP-1 (mmHg)[\*](#tfn2-cln_68p33){ref-type="table-fn"})            10 (9-11)                     10 (8-12)                  0.883
  CVP-2 (mmHg)\*\*                                                   9 (5-10)                      11 (9-15)                  0.023
  PCP-1 (%)[\*](#tfn2-cln_68p33){ref-type="table-fn"})^\$^           14 (13-15)                    14 (10-17)                 0.855
  PCP-2 (%)[\*](#tfn2-cln_68p33){ref-type="table-fn"})^\$^           10 (9-12)                     12 (9-15)                  0.440
  ScvO~2~-1 (%)\*\*                                                  77 (70-81)                    77 (69-77)                 0.781
  ScvO~2~-2 (%)[\*](#tfn2-cln_68p33){ref-type="table-fn"})           69 (68-71)                    62 (58-65)                 0.002
  CI-1 (L/min/m^2^)^\$^[\*](#tfn2-cln_68p33){ref-type="table-fn"})   3.17 (2.83-3.50)              2.75 (2.31-3.20)           0.361
  CI-2 (L/min/m^2^)^\$^[\*](#tfn2-cln_68p33){ref-type="table-fn"})   3.33 (3.08-3.58)              2.76 (2.21-3.30)           0.068
  Lactate-1 (mmol/L)\*\*                                             4.0 (2.9-6.1)                 2.3 (1.3-5.0)              0.313
  Lactate-2 (mmol/L)\*\*                                             2.9 (1.8-4.6)                 1.9 (1.4-3.6)              0.296
  Hb-1 (g/dL)\*\*                                                    10.8 (9.8-11.8)               9.8 (9.2-11.7)             0.154
  Hb-2 (g/dL)\*\*                                                    10.6 (9.6-11.8)               10 (8.9-10.2)              0.084
  Dobutamine-1\*\*                                                   10 (8-17)                     14 (9-18)                  0.519
  Dobutamine-2\*\*                                                   12 (9-16)                     15 (11-18)                 0.044
  Respiratory                                                                                                                 
  PaO~2~-1 (mmHg)[\*](#tfn2-cln_68p33){ref-type="table-fn"})         145 (136-154)                 142 (113-171)              0.754
  PaO~2~-2 (mmHg)\*\*                                                107 (90-143)                  117 (88-152)               0.550
  PaCO~2~-1 (mmHg)\*\*                                               40 (36-44)                    39 (36-45)                 0.806
  PaCO~2~-2 (mmHg)\*\*                                               37 (33-40)                    37 (34-41)                 0.303
  pH-1\*\*                                                           7.3 (7.3-7.4)                 7.4 (7.3-7.4)              0.313
  pH-2\*\*                                                           7.4 (7.3-7.4)                 7.4 (7.3-7.4)              0.232
  Tobin-2\*\*                                                        36 (26-45)                    45 (29-83)                 0.098
  SC-1 (mL/cmH~2~O)\*\*                                              38 (32-49)                    39 (33-51)                 0.889
  Natriopeptides (ng/L)                                                                                                       
  BNP-1\*\*                                                          73 (28-127)                   214 (65-487)               0.020
  BNP-2\*\*                                                          140 (80-226)                  416 (311-561)              \<0.001

\*mean (95% Confidence Interval), t-test, \*\*median (Interquartile Range), Mann-Whitney test. ^\$^evaluated in the 44 patients who had a pulmonary artery catheter inserted -- 36 in the successful weaning group and 8 in the failure to wean group. 1- at intensive care unit admission; 2- at the end of the spontaneous breathing test; HR: heart rate; MAP: mean arterial pressure; PAOP: pulmonary artery occlusion pressure; CVP: central venous pressure; ScvO~2~: central venous oxygen saturation; Hb: hemoglobin concentration; SC =  Static compliance; CI: cardiac index.
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